Publications

Clewell HJ, Gentry PR, Covington TR, Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol Sci 79(2):381–93.

Lau C, JL Butenhoff, JM Rogers. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241; doi: 10.1016/j.taap.2003.11.031.

Lea IA, Widgren EE, O’Rand MG. 2004. Association of sperm protein 17 with A-kinase anchoring protein 3 in flagella. Reprod Biol Endocrinol 2(Jul 16):57; doi: 10.1186/1477-7827-2-57.

Jahnke GD, Choksi NY, Moore JA, Shelby MD. 2004. Thyroid toxicants: Assessing reproductive health effects. Environ Health Perspect 112(3):363–368; doi: 10.1289/ehp.6637.

Kelsh MA, Bracken TD, Sahl JD, Shum M, Ebi KL. 2003. Occupational magnetic field exposures of garment workers: Results of personal and survey measurements. Bioelectromagnetics 24:316–326.

Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect 112(1):9-17; doi: 10.1289/ehp.6559.

Birnbaum LS, Staskal DF, Diliberto JJ. 2003. Health effects of polybrominated dibenzo-p-dioxins (PBDDs) and dibenzofurans (PBDFs). Environ Inter. 29(6): 855-860; doi: 10.1016/S0160-4120(03)00106-5.

Gentry RP, Covington TR, Clewell HJ III. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 38(1):1–16; doi: 10.1016/S0273-2300(03)00047-3.

Proctor D, Panko J, Liebig E, Mundt K, Buczynski M, Barnhart R, Harris MA, Morgan R, Finley B, Paustenbach D. 2003. Workplace concentrations of airborne hexavalent chromium for the Painesville, Ohio chromate production plant. Appl Occup Environ Hyg 18(6):430-449; doi: 10.1080/10473220301421.

Luippold RS, Mundt KA, Austin RP, Liebig EW, Panko JM, Crump C, Crump K, Proctor DM. 2003. Lung cancer mortality among chromate production workers. J Occup Environ Med 60:451–457.

Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig EW, Panko JM, Paustenbach DJ, Proctor DM. 2003. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Anal 23(6):1147–1163; doi: 10.1111/j.0272-4332.2003.00388.x.

Turesky RJ, Richoz J, Constable A, Curtis KD, Dingley KH, Turteltaub KW. 2003. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Chem-Biol Interact 145(3):251–265; doi: 10.1016/S0009-2797(03)00022-X. PMID: 12732453.

Dingley KH, Ubick EA, Chiarappa-Zucca ML, Nowell S, Abel S, Ebeler SE, et al. 2003. Effect of dietary constituents with chemopreventive potential on adduct formation of a low-dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer 46(2):212–221; doi: 10.1207/S15327914NC4602_15. PMID: 14690798.

Martin EA, Gaskell M, Al-Azzawi F, Garner RC, Brown K, Boocock DJ, Mattock E, Pring DW, Dingley K, et al. 2003. Tamoxifen DNA damage detected in human endometrium using the ultra sensitive technique of accelerator mass spectrometry. Cancer Res 63(23):8461–8465. PMID: 14679010.

Hanna LA, Clegg MS, Momma T, Rogers JM, Daston GP, Keen CL. 2003. Zinc influences the in vitro development of peri-implantation mouse embryos. Birth Defects Res A 67(6):414–420; doi: 10.1002/bdra.10046.

Leazer TM, Daston GP, Keen CL, Rogers JM. 2003. The embryolethality of lipopolysaccharide in CD-1 and metallothionein I-II null mice: Lack of a role for induced zinc deficiency or metallothionein induction. Toxicol Sci 73(2):442–447; doi: 10.1093/toxsci/kfg088.

Tarka-Leeds DK, Suarez JD, Roberts NL, Rogers JM, Hardy MP, Klinefelter GR. 2003. Gestational exposure to ethane dimethanesulfonate permanently alters reproductive competence in the CD-1 mouse. Biol Reprod 69(3):959–967; doi: 10.1095/biolreprod.103.017343.

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74(2):369–381; doi: 10.1093/toxsci/kfg121.

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74(2):382–292; doi: 10.1093/toxsci/kfg122.

Rogers JM, Abbott BD. 2003. Screening for developmental toxicity of tobacco smoke constituents. Toxicol Sci 75(2):227–228; doi: 10.1093/toxsci/kfg215.